Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
SGMT on Nasdaq
David Happel - trading volume in the past year for Sagimet Biosciences Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Series A Common Stock |
639K |
$3.37M |
$5.27 |
Mar 26, 2024 |
Direct |
|
|
Stock Option (Right to Buy) |
1.01M |
|
|
Jul 18, 2023 |
Direct |
Series A Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.